OTIPAX

This brand name is authorized in Estonia, France, Lithuania, Malta, Romania, Tunisia

Active ingredients

The drug OTIPAX contains a combination of these active pharmaceutical ingredients (APIs):

1 Phenazone UNII T3CHA1B51H - ANTIPYRINE

Phenazone has analgesic and antipyretic properties. Topically, solutions have been used locally as ear drops in disorders such as otitis media because of its local anti-inflammatory and analgesic action. Read about Phenazone

2 Lidocaine UNII V13007Z41A - LIDOCAINE HYDROCHLORIDE

Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane. Read about Lidocaine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S02DA30	Combinations	S Sensory organs → S02 Otologicals → S02D Other otologicals → S02DA Analgesics and anesthetics
Discover more medicines within S02DA30

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1172506
Country: FR	Base de données publique des médicaments	Identifier(s): 69668703
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1006980
Country: MT	Medicines Authority	Identifier(s): MA239/00201
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W58408001
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5193041, 9013281